全文获取类型
收费全文 | 3403篇 |
免费 | 199篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 118篇 |
妇产科学 | 136篇 |
基础医学 | 470篇 |
口腔科学 | 79篇 |
临床医学 | 315篇 |
内科学 | 756篇 |
皮肤病学 | 72篇 |
神经病学 | 280篇 |
特种医学 | 67篇 |
外科学 | 367篇 |
综合类 | 30篇 |
一般理论 | 1篇 |
预防医学 | 264篇 |
眼科学 | 85篇 |
药学 | 270篇 |
中国医学 | 11篇 |
肿瘤学 | 273篇 |
出版年
2023年 | 14篇 |
2022年 | 33篇 |
2021年 | 61篇 |
2020年 | 43篇 |
2019年 | 68篇 |
2018年 | 69篇 |
2017年 | 51篇 |
2016年 | 50篇 |
2015年 | 87篇 |
2014年 | 99篇 |
2013年 | 135篇 |
2012年 | 234篇 |
2011年 | 242篇 |
2010年 | 105篇 |
2009年 | 108篇 |
2008年 | 242篇 |
2007年 | 241篇 |
2006年 | 218篇 |
2005年 | 249篇 |
2004年 | 210篇 |
2003年 | 206篇 |
2002年 | 170篇 |
2001年 | 65篇 |
2000年 | 70篇 |
1999年 | 55篇 |
1998年 | 36篇 |
1997年 | 29篇 |
1996年 | 17篇 |
1995年 | 22篇 |
1994年 | 23篇 |
1993年 | 25篇 |
1992年 | 39篇 |
1991年 | 37篇 |
1990年 | 42篇 |
1989年 | 24篇 |
1988年 | 19篇 |
1987年 | 21篇 |
1986年 | 23篇 |
1985年 | 17篇 |
1984年 | 10篇 |
1983年 | 11篇 |
1982年 | 7篇 |
1979年 | 7篇 |
1977年 | 13篇 |
1976年 | 5篇 |
1973年 | 6篇 |
1972年 | 7篇 |
1970年 | 10篇 |
1969年 | 4篇 |
1966年 | 10篇 |
排序方式: 共有3612条查询结果,搜索用时 31 毫秒
91.
Ellen C. Keeley Matthew Villanueva Yiqing E. Chen Yan Gong Eileen M. Handberg Steven M. Smith Carl J. Pepine Rhonda M. CooperDeHoff 《Journal of clinical hypertension (Greenwich, Conn.)》2020,22(11):1987
Recent clinical guidelines recommend lower blood pressure (BP) goals for most patients, and recent trends have favored use of automated unattended BP measurements in the office setting to minimize observer error and white‐coat effects. Patients attending a routinely scheduled CVD clinic visit were prospectively randomized to BP measured using an attended, followed by an unattended method, or vice versa, after a controlled rest period. All study BP measurements were obtained in triplicate using the automated Omron HEM‐907XL BP monitor, and averaged. The outcome was difference in SBP. Routinely measured clinic BP from the same visit was extracted from the medical record, and compared with attended and unattended BP. A total of 102 patients were randomized, and mean age was 63 years, 52% female and 75% Caucasian. Attended and unattended SBP was 125.4 ± 20.4 and 122.6 ± 21.0 mm Hg, mean ± SD, respectively. Routine clinic SBP was 130.6 ± 23.6 mm Hg. Attended SBP was 2.7 mm Hg higher than the unattended measurement (95% CI 1.3‐4.1; P = .0002). Routine clinic SBP was 5.2 mm Hg higher than attended SBP (95% CI 2.4‐8.0; P = .0003) and 8.0 mm Hg higher than unattended SBP (95% CI 5.4‐10.5; P < .0001). Attended measurement of BP is significantly higher than unattended measurement and the difference is physiologically meaningful, even in a CVD cohort with generally well‐controlled hypertension. Furthermore, routine clinic SBP substantially overestimates both attended and unattended automated SBP, with important implications for treatment decisions like dose and/or drug escalation. 相似文献
92.
P Labarga P Barreiro A da Silva JM Guardiola R Rubio K Aguirrebengoa P Miralles J Portu MJ Téllez L Morano A Castro JA Pineda A Terrón J Hernández-Quero A Mariño MJ Ríos S Echeverría V Asensi E Vispo V Soriano;on behalf of PERICO Study Group 《The Journal of infectious diseases》2012,206(6):961-968
Background.?Ribavirin (RBV) exposure seems to be critical to maximize treatment response in human immunodeficiency virus (HIV)-positive patients with chronic hepatitis C virus (HCV) infection. Methods.?HIV/HCV-coinfected individuals naive to interferon were prospectively randomized to receive peginterferon-α-2a (180?μg/d) plus either RBV standard dosing (1000 or 1200?mg/d if <75 or ≥75?kg, respectively) or RBV induction (2000?mg/d) along with subcutaneous erythropoietin β (450?IU/kg/wk), both during the first 4 weeks, followed by standard RBV dosing until completion of therapy. Early stopping rules at weeks 12 and 24 were applied in patients with suboptimal virological response. Results.?A total of 357 patients received ≥1 dose of the study medication. No differences in main baseline characteristics were found when comparing treatment arms. Sustained virological response (SVR) was attained by 160 (45%) patients, with no significant differences between RBV induction and standard treatment arms (SVR in 72 of 169 patients [43%] vs 88 of 188 [47%], respectively). At week 4, undetectable HCV RNA (29% vs 25%) and mean RBV trough concentration (2.48 vs 2.14?μg/mL) were comparable in both arms, whereas mean hemoglobin decay was less pronounced in the RBV induction plus erythropoietin arm than in the RBV standard dosing arm (-1.7 vs -2.3?mg/dL; P?.005). Treatment discontinuation occurred in 91 (25%) patients owing to nonresponse and in 29 (8%) owing to adverse events. HCV relapse occurred in 34 patients (10%). Univariate and multivariate analyses identified HCV genotype 2 or 3 (odds ratio [OR], 10.3; 95% confidence interval [CI], 2.08-50.2; P?=?.004), IL28B CC variants (OR, 2.92; 95% CI, 1.33-6.41; P?=?.007), nonadvanced liver fibrosis (OR, 2.27; 95% CI, 1.06-5.01; P?=?.03), and rapid virological response (OR, 40.3; 95% CI, 5.1-314.1; P?.001) as predictors of SVR. Conclusions.?A 4-week course of induction therapy with high RBV dosing along with erythropoietin does not improve SVR rates in HIV/HCV-coinfected patients. Preemptive erythropoietin might blunt the benefit of RBV overdosing by enhancing erythrocyte uptake of plasma RBV. 相似文献
93.
94.
Perez-Sanchez C Ruiz-Limon P Aguirre MA Bertolaccini ML Khamashta MA Rodriguez-Ariza A Segui P Collantes-Estevez E Barbarroja N Khraiwesh H Gonzalez-Reyes JA Villalba JM Velasco F Cuadrado MJ Lopez-Pedrera C 《Blood》2012,119(24):5859-5870
The exact mechanisms underlying the role of oxidative stress in the pathogenesis and the prothrombotic or proinflammatory status of antiphospholipid syndrome (APS) remain unknown. Here, we investigate the role of oxidative stress and mitochondrial dysfunction in the proatherothrombotic status of APS patients induced by IgG-antiphospholipid antibodies and the beneficial effects of supplementing cells with coenzyme Q(10) (CoQ(10)). A significant increase in relevant prothrombotic and inflammatory parameters in 43 APS patients was found compared with 38 healthy donors. Increased peroxide production, nuclear abundance of Nrf2, antioxidant enzymatic activity, decreased intracellular glutathione, and altered mitochondrial membrane potential were found in monocytes and neutrophils from APS patients. Accelerated atherosclerosis in APS patients was found associated with their inflammatory or oxidative status. CoQ(10) preincubation of healthy monocytes before IgG-antiphospholipid antibody treatment decreased oxidative stress, the percentage of cells with altered mitochondrial membrane potential, and the induced expression of tissue factor, VEGF, and Flt1. In addition, CoQ(10) significantly improved the ultrastructural preservation of mitochondria and prevented IgG-APS-induced fission mediated by Drp-1 and Fis-1 proteins. In conclusion, the oxidative perturbation in APS patient leukocytes, which is directly related to an inflammatory and pro-atherothrombotic status, relies on alterations in mitochondrial dynamics and metabolism that may be prevented, reverted, or both by treatment with CoQ(10). 相似文献
95.
Blocking ephrinB2 with highly specific antibodies inhibits angiogenesis, lymphangiogenesis, and tumor growth 总被引:1,自引:0,他引:1
Abéngozar MA de Frutos S Ferreiro S Soriano J Perez-Martinez M Olmeda D Marenchino M Cañamero M Ortega S Megias D Rodriguez A Martínez-Torrecuadrada JL 《Blood》2012,119(19):4565-4576
Membrane-anchored ephrinB2 and its receptor EphB4 are involved in the formation of blood and lymphatic vessels in normal and pathologic conditions. Eph/ephrin activation requires cell-cell interactions and leads to bidirectional signaling pathways in both ligand- and receptor-expressing cells. To investigate the functional consequences of blocking ephrinB2 activity, 2 highly specific human single-chain Fv (scFv) Ab fragments against ephrinB2 were generated and characterized. Both Ab fragments suppressed endothelial cell migration and tube formation in vitro in response to VEGF and provoked abnormal cell motility and actin cytoskeleton alterations in isolated endothelial cells. As only one of them (B11) competed for binding of ephrinB2 to EphB4, these data suggest an EphB-receptor-independent blocking mechanism. Anti-ephrinB2 therapy reduced VEGF-induced neovascularization in a mouse Matrigel plug assay. Moreover, systemic administration of ephrinB2-blocking Abs caused a drastic reduction in the number of blood and lymphatic vessels in xenografted mice and a concomitant reduction in tumor growth. Our results show for the first time that specific Ab-based ephrinB2 targeting may represent an effective therapeutic strategy to be used as an alternative or in combination with existing antiangiogenic drugs for treating patients with cancer and other angiogenesis-related diseases. 相似文献
96.
97.
Pérez Aisa A Nuevo J López Morante AA González Galilea A Martin de Argila C Aviñoa Arreal D Feu F Borda Celaya F Gisbert JP Pérez Roldan F Gonzalvo Sorribes JM Palazón Azorín JM Ponce Romero M Castro Fernández M Catalina Rodriguez MV Gallego Montañés S Calvet X Rodrigo Saez L Montoro Huguet M González Méndez Y Sierra Hernández A Sánchez Hernández E Dominguez Muñoz E Pérez Cuadrado E Muñoz M Lanas A 《Gastroenterologia y hepatologia》2012,35(7):468-475
98.
Pérez Moreiras MI Alvarez Gutierrez AE Couselo Villanueva JM Iglesias Porto E González López R Arija Val F 《Gastroenterologia y hepatologia》2012,35(7):476-479
Meckel's diverticulum (MD) is a persistent embryonic remnant occurring in 2% of the general population. This entity is usually clinically silent and is only discovered when complications occur. Diagnosis is rarely made preoperatively. Surgical resection of symptomatic MD is widely accepted but the most appropriate management of asymptomatic MD remains unclear. We present a case of MD that summarizes some of the complications that may occur. The peculiarity of this case was that the complications were caused by a leiomyoma. The presence of tumoral disease in MD accounts for 3.2% of complications. The most common neoplasm is carcinoid tumor. Few publications have reported benign neoplasms in MD, probably due to their low incidence. 相似文献
99.
100.
Bello S Lasierra AB Mincholé E Fandos S Ruiz MA Vera E de Pablo F Ferrer M Menendez R Torres A 《The European respiratory journal》2012,39(5):1144-1155
Biomarkers are useful in community-acquired pneumonia (CAP). Recently, midregional (MR) proadrenomedullin (proADM) has been shown to be of potential prognostic use. We sought to determine whether this prognostic role depends on the cause of CAP. We conducted a prospective cohort study of immunocompetent patients with CAP. Pneumonia Severity Index (PSI) and CURB-65 score (confusion (abbreviated mental test score of ≤ 8), urea ≥ 7 mol · L(-1), respiratory rate ≥ 30 breaths · min(-1), blood pressure <90 mmHg systolic or <60 mmHg diastolic, and age ≥ 65 yrs), blood C-reactive protein, procalcitonin, MR-proADM, and microbiological studies were systematically performed. Patients were grouped as bacterial, viral/atypical and mixed CAP, and were followed up at 30, 90 and 180 days, and 1 yr. We recruited 228 CAP patients. Identification of at least one pathogen was achieved in 155 (68%) patients. MR-proADM levels closely correlated with increasing severity scores, and showed an important predictive power for complications and short- and long-term mortality (1 yr). Its addition to PSI and CURB-65 significantly improved their prognostic accuracy. A MR-proADM cut-off of 0.646 nmol · L(-1) identified 92% of patients scored as PSI classes IV and V as high risk. MR-proADM outcome prediction power was not affected by different aetiologies. MR-proADM has high short- and long-term prognostic accuracy, and increases the accuracy of clinical scores. The prognostic value of MR-proADM is not modified by different possible CAP aetiologies. 相似文献